TCF7L2 regulates pancreatic β-cell function through PI3K/AKT signal pathway

Area of Science:

• Molecular Biology
• Endocrinology
• Genetics

Background:

• Transcription factor 7-like 2 (TCF7L2) is linked to diabetes susceptibility and influences WNT signaling.
• TCF7L2's role in pancreatic beta-cell function, particularly its regulation of the PI3K/AKT pathway, is not fully understood.

Purpose of the Study:

• To investigate the mechanistic role of TCF7L2 in regulating pancreatic beta-cell function.
• To elucidate the relationship between TCF7L2, PI3K/AKT signaling, and insulin secretion.

Main Methods:

• MIN6 cells were manipulated using TCF7L2 knockdown or overexpression viruses.
• Western blotting assessed PI3K p85 and p-Akt expression; ELISA measured insulin secretion.
• Chromatin immunoprecipitation, PCR, and luciferase reporter assays identified TCF7L2 binding sites in the PIK3R1 promoter.

Main Results:

• TCF7L2 significantly inhibited PIK3R1 gene and PI3K p85 protein expression.
• This inhibition led to PI3K/AKT pathway activation and stimulated insulin secretion.
• The TCF7L2-binding motif's integrity was critical for binding affinity to the PIK3R1 promoter.

Conclusions:

• TCF7L2 binds to specific regions of the PIK3R1 promoter, controlling p85 transcription.
• TCF7L2 influences PI3K/AKT signaling activation and insulin secretion in pancreatic beta cells.